By Bhanvi Satija LONDON, April 12 (Reuters) - British drugmaker GSK's experimental targeted cancer drug Mo-rez has ...
LONDON/PARIS, Dec 7 (Reuters) - Shares of GSK GSK.L and Sanofi SASY.PA surged in early trading on Wednesday, following the dismissal of thousands of U.S. lawsuits claiming that the heartburn drug ...
The FDA has approved Alfasigma's primary biliary cholangitis (PBC) therapy linerixibat, just days after the company licensed it from GSK in a deal worth up to $690 million. The US regulator confirmed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results